Stanford researchers transplant human brain organoids into genetically modified mice

Genetic engineering and organoid transplantation

Researchers at Stanford University have developed an experimental platform that replaces missing brain structures in mice with living human brain tissue. In a study published on 16 September 2026 in Nature, scientists led by neuroscientist Sergiu Pașca genetically altered mice to block the development of the cerebral cortex and hippocampus. Because the cerebral cortex governs higher-level cognitive tasks such as attention, language, and decision-making, the modification left a void occupying roughly half of normal brain volume. The researchers then derived three-dimensional human cortical organoids by reprogramming human skin and blood cells into pluripotent stem cells. Newborn mice received multiple targeted injections into the skull cavity, with each injection containing approximately 100,000 human brain cells.

Integration and cellular development

Rather than remaining isolated in the cranial cavity, the transplanted human cells grew and formed functional neural networks throughout the host nervous system. Over subsequent weeks, the human tissue integrated with the host blood vessels and established axonal projections reaching into the mouse spinal cord. Three months after the procedure, more than 90% of the cortical tissue inside the rodent brain was human in origin. The grafted tissue also differentiated into specialized cells that typically appear only in humans and other primates, including rare von Economo neurons linked to frontotemporal dementia.

“In these mice, the human grafts generated a broad diversity of cortical cell types and established functional connections throughout the mouse nervous system.”

Animal behavior and disease mechanisms

The bioengineered animals survived the procedure because adjacent subcortical brain structures compensated for the absent tissue. At six months of age, the mice performed tasks similarly to unmodified control animals, exhibiting only minor memory deficits and a slightly more cautious walking gait attributed to altered fine motor control. The model provides an experimental setting to observe how genetic mutations affect intact neural circuits, moving beyond the physical limits of flat petri dishes and non-vascularized organoids. In laboratory trials, researchers demonstrated that the grafted human neurons were sensitive to oxygen deprivation, a biological stressor linked to cerebral palsy, epilepsy, and autism during perinatal development.

“It is as if the mouse were an incubator.”

Clinical applications and ethical oversight

The Stanford team intends to derive cells from patients diagnosed with frontotemporal dementia, severe autism, and schizophrenia to test candidate drugs directly in living tissue. Stefano Gustincich, director of the Center for Clinical and Computational Genomics at the Italian Institute of Technology in Aosta, stated that the technique could enable researchers to study aging mechanisms and explore future patient-derived neural transplants. Addressing concerns regarding animal welfare and potential cognitive changes, Pașca confirmed that the research project operated under continuous ethical supervision from its inception.

“This gives us a way to study human neural tissue across several levels, from genes and individual cell types to circuits and functional consequences in an animal.”